Phenomen Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly (NCT07068191) | Phenomen Pharma | 2025-06-19 |
Track Phenomen Pharma automatically
Every clearance here is in the API, with alerts when new ones post.